van Doorn, L.; Crombag, M.-R.B.S.; Rier, H.N.; van Vugt, J.L.A.; van Kesteren, C.; Bins, S.; Mathijssen, R.H.J.; Levin, M.-D.; Koolen, S.L.W.
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients. Pharmaceuticals 2021, 14, 47.
https://doi.org/10.3390/ph14010047
AMA Style
van Doorn L, Crombag M-RBS, Rier HN, van Vugt JLA, van Kesteren C, Bins S, Mathijssen RHJ, Levin M-D, Koolen SLW.
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients. Pharmaceuticals. 2021; 14(1):47.
https://doi.org/10.3390/ph14010047
Chicago/Turabian Style
van Doorn, Leni, Marie-Rose B. S. Crombag, Hánah N. Rier, Jeroen L. A. van Vugt, Charlotte van Kesteren, Sander Bins, Ron H. J. Mathijssen, Mark-David Levin, and Stijn L. W. Koolen.
2021. "The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients" Pharmaceuticals 14, no. 1: 47.
https://doi.org/10.3390/ph14010047
APA Style
van Doorn, L., Crombag, M.-R. B. S., Rier, H. N., van Vugt, J. L. A., van Kesteren, C., Bins, S., Mathijssen, R. H. J., Levin, M.-D., & Koolen, S. L. W.
(2021). The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients. Pharmaceuticals, 14(1), 47.
https://doi.org/10.3390/ph14010047